One mutation would result in a truncated product that lacks all the β-catenin binding domains analogous to ApcΔ580 mutation, while the other was located in the same region where mutations in K14-Cre; ApcCKO/+ mammary tumors were found. Here, KRT14 is linked to breast cancer.